My watch list
my.bionity.com  
Login  
NEWS
Current news

Merck Named a Top Employer by Science Magazine

Survey ranks Merck fourth among the world’s top employers

Merck announced it was ranked fourth among biotechnology and pharmaceutical companies worldwide by Science magazine, a leading peer-reviewed international scientific publication. This ranking marks the fourth year in a row Merck was named one of the top 20 employers in the healthcare and li ... more

Integrated lab-on-a-chip uses smartphone to quickly detect multiple pathogens

A multidisciplinary group that includes the University of Illinois at Urbana-Champaign and the University of Washington at Tacoma has developed a novel platform to diagnose infectious disease at the point-of-care, using a smartphone as the detection instrument in conjunction with a test kit ... more

Protecting patents by Native Americans

By using a novel patent strategy companies try to protect their intellectual property in the US. And this is how it works: Giving your patent to a body called “sovereign immunites” makes this patent not attackable to a patent review called IPR (inter partes review). A large pharmaceutical c ... more

Herbal remedies containing aristolochic acid may cause liver cancer

Scientists from Singapore and Taiwan have revealed a decisive link between Aristolochic Acids (AA), a natural product of some plants used in herbal remedies, and liver cancers. Using mutational signature analysis, the researchers found that liver tumours had been exposed to AA, which had mu ... more

Explaining how UV rays trigger skin cancer

Melanoma, a cancer of skin pigment cells called melanocytes, will strike an estimated 87,110 people in the U.S. in 2017, according to the Centers for Disease Control and Prevention. A fraction of those melanomas come from pre-existing moles, but the majority of them come from sources unknow ... more

Innovative Extraction Technologies

Getting More From Biomass

Swedish-Finnish company Stora Enso is undergoing a renewable materials transformation. Previously focused on pulp and paper, the company is developing new, innovative products and services based on wood and other non-food competing feedstock. The goal – to replace non-renewable materials an ... more

Possible new immune therapy target in lung cancer

A study from Bern University Hospital in collaboration with the University of Bern shows that so-called perivascular-like cells from lung tumors behave abnormally. They not only inadequately support vascular structures, but also may actively modulate the inflammatory and immune response. Th ... more

STA Pharmaceutical to open new transition metal catalysis center

The center will allow STA to introduce transition metal catalyst-screening technology to their existing small molecule process development and manufacturing platform. STA Pharmaceutical, a WuXi AppTec company, has announced plans to launch a new transition metal catalysis center at their in ... more

Releasing the brakes on the immune system

Many tumors possess mechanisms to avoid destruction by the immune system. For instance, they misuse the natural “brakes” in the immune defense mechanism, which normally prevent an excessive immune response. Researchers at the University of Bonn have now been able to take off one of these br ... more

Biesterfeld Spezialchemie: New business unit combines healthcare distribution activities

As part of its ongoing drive to develop market segment focus, Biesterfeld Spezialchemie is creating a new business unit for healthcare distribution. This move is a logical continuation of previous developments and will allow the distributor to effectively target this highly demanding market ... more

All news

Explaining how UV rays trigger skin cancer

Melanoma, a cancer of skin pigment cells called melanocytes, will strike an estimated 87,110 people in the U.S. in 2017, according to the Centers for Disease Control and Prevention. A fraction of those melanomas come from pre-existing moles, but the majority of them come from sources unknow ... more

Neutrons observe vitamin B6-dependent enzyme activity useful for drug development

Scientists at the Department of Energy's Oak Ridge National Laboratory have performed neutron structural analysis of a vitamin B6-dependent protein, potentially opening avenues for new antibiotics and drugs to battle diseases such as drug-resistant tuberculosis, malaria and diabetes. Specif ... more

Mechanism involved in novel drug design with potential to treat tuberculosis

A team of researchers from Instituto de Medicina Molecular (iMM) Lisboa successfully used a pioneer method to chemically modify a protein's components with potential medical applications and an impact in the fight against tuberculosis. To design novel drugs it is essential to understand the ... more

Nanoscale virus features reconstructed from correlations of scattered X-rays

As part of an international research team, Jeff Donatelli, Peter Zwart and Kanupriya Pande of the Center for Advanced Mathematics for Energy Research Applications (CAMERA) at Lawrence Berkeley National Laboratory (Berkeley Lab) contributed key algorithms which helped achieve a goal first pr ... more

Pioneering discovery of an odor-detecting receptor enhancer

Each odor-detecting neuron (referred to as olfactory sensory neuron from here on), chooses a single odorant receptor gene from a fairly large number of options that are split into class I (fish-like) and class II (terrestrial-specific) odorant receptors. This strict selectiveness of sensory ... more

Eurofins acquires LGC Forensics

Eurofins Scientific announces that it has signed an agreement to acquire the Forensics and Security division of LGC (“LGC Forensics”), the largest player in the UK forensics market, a European pioneer in this field and a significant forensic DNA testing provider in Germany, from LGC Group. ... more

Bacteria self-organize to build working sensors

Researchers at Duke University have turned bacteria into the builders of useful devices by programming them with a synthetic gene circuit. As a bacterial colony grows into the shape of a hemisphere, the gene circuit triggers the production of a type of protein to distribute within the colon ... more

Genome architecture caught in motion

Researchers at The Wistar Institute have uncovered new aspects of the three-dimensional organization of the genome, specifically how the genetic material is compacted and de-compacted in a timely fashion during the different phases of the cell cycle. "We are just starting to appreciate that ... more

Heptares founder Richard Henderson receives Nobel Prize in Chemistry 2017

Heptares Therapeutics is delighted that one of its founders, Richard Henderson (MRC Laboratory of Molecular Biology, Cambridge, UK), was awarded the Nobel Prize in Chemistry 2017 together with Jacques Dubochet (University of Lausanne, Switzerland) and Joachim Frank (Columbia University, New ... more

Cool microscope technology revolutionises biochemistry

We may soon have detailed images of life’s complex machineries in atomic resolution. The Nobel Prize in Chemistry 2017 is awarded to Jacques Dubochet, Joachim Frank and Richard Henderson for the development of cryo-electron microscopy, which both simplifies and improves the imaging of biomo ... more

All news on bioanalytics

Merck Named a Top Employer by Science Magazine

Survey ranks Merck fourth among the world’s top employers

Merck announced it was ranked fourth among biotechnology and pharmaceutical companies worldwide by Science magazine, a leading peer-reviewed international scientific publication. This ranking marks the fourth year in a row Merck was named one of the top 20 employers in the healthcare and li ... more

Innovative Extraction Technologies

Getting More From Biomass

Swedish-Finnish company Stora Enso is undergoing a renewable materials transformation. Previously focused on pulp and paper, the company is developing new, innovative products and services based on wood and other non-food competing feedstock. The goal – to replace non-renewable materials an ... more

Neutrons observe vitamin B6-dependent enzyme activity useful for drug development

Scientists at the Department of Energy's Oak Ridge National Laboratory have performed neutron structural analysis of a vitamin B6-dependent protein, potentially opening avenues for new antibiotics and drugs to battle diseases such as drug-resistant tuberculosis, malaria and diabetes. Specif ... more

SimPath licenses novel ORNL system for enhanced synthetic biology

SimPath has licensed a novel cloning system developed by the Department of Energy's Oak Ridge National Laboratory that generates and assembles the biological building blocks necessary to synthetically bioengineer new medicines and fuels. Knoxville, Tennessee-based startup SimPath will furth ... more

Plasticell and GSK sign collaboration agreement

Contains production of hematopoietic cells from iPSCs

Plasticell, the biotechnology company specialising in stem cell screening and cell therapy development, has entered into a collaboration with GSK to use its combinatorial stem cell screening technology, CombiCult®, to optimise the directed differentiation of induced pluripotent stem cells ( ... more

The ghosts of HeLa

Some 30,000 biomedical publications report on misidentified cells

For decades, immortal cells such as the famous HeLa cells have been contaminating other cell cultures in the lab. As a result, scientific studies about certain cells are actually discussing other cells. Willem Halffman and Serge Horbach, researchers at Radboud University, found more than 30 ... more

Mechanism involved in novel drug design with potential to treat tuberculosis

A team of researchers from Instituto de Medicina Molecular (iMM) Lisboa successfully used a pioneer method to chemically modify a protein's components with potential medical applications and an impact in the fight against tuberculosis. To design novel drugs it is essential to understand the ... more

One if by editing, two if by roadblock

Human protein fights HIV as monomer and dimer

Fifteen years ago, a class of proteins was discovered, which give humans innate immunity to HIV-1. Unfortunately, HIV-1 is a smart virus and has evolved to battle these proteins. Northeastern researchers, with help from their collaborators, have been studying these proteins for several year ... more

How the cone snail's deadly venom can help us build better medicines

Cone snails have inspired humans for centuries. Coastal communities have often traded their beautiful shells like money and put them in jewelry. Many artists, including Rembrandt, have featured them in sketches and paintings. Now, scientists at the National Institute of Standards and Techno ... more

Pertinax Pharma launches patented chlorhexidine technology

Novel materials enable controlled and sustained release of chlorhexidine

Pertinax Pharma today announces the commercial launch of its unique, proprietary Pertinax® technology, which provides controlled and sustained delivery of chlorhexidine (CHX). The revolutionary new technology has a wide range of potential applications across the wound care, dentistry, medic ... more

All news on biotechnology

Integrated lab-on-a-chip uses smartphone to quickly detect multiple pathogens

A multidisciplinary group that includes the University of Illinois at Urbana-Champaign and the University of Washington at Tacoma has developed a novel platform to diagnose infectious disease at the point-of-care, using a smartphone as the detection instrument in conjunction with a test kit ... more

Initiative taps scientists to create atlas of cells in human spinal cord

Scientists at Columbia's Zuckerman Institute today received a grant from the Chan Zuckerberg Initiative (CZI) donor advised fund, an advised fund of the Silicon Valley Community Foundation, to construct an atlas of gene activity of all cells in the human spinal cord. Once completed, the atl ... more

Mechanism explains how seizures may lead to memory loss

Although it's been clear that seizures are linked to memory loss and other cognitive deficits in patients with Alzheimer's disease, how this happens has been puzzling. In a study a team of researchers reveals a mechanism that can explain how even relatively infrequent seizures can lead to l ... more

Proteins may prevent dysfunction and disease by relaxing

For many years, we thought that all proteins must fold into complicated shapes to fulfill their functions, looking like thousands of sets of custom-tailored locks and keys. But over the past two decades, scientists have begun to realize other proteins -- including those involved in many ess ... more

New antibiotic resistance genes found

Researchers at Chalmers University of Technology and the University of Gothenburg, Sweden, have found several previously unknown genes that make bacteria resistant to last-resort antibiotics. The genes were found by searching large volumes of bacterial DNA. The increasing number of infectio ... more

Major breakthrough identifies new mechanism for the development of schizophrenia

Scientists from Trinity College Dublin and the Royal College of Surgeons in Ireland (RCSI) have discovered that abnormalities of blood vessels in the brain may play a major role in the development of schizophrenia, a debilitating condition that affects around 1% of people in Ireland. The ne ... more

Not all fish are created equal

Having a fish allergy does not mean you have to avoid eating fish

So far, the general recommendation for those with a fish allergy has been to completely abstain from eating fish. Now however, an international research team, including Dr Annette Kühn and Professor Markus Ollert from the Luxembourg Institute of Health (LIH) and Dr Martin Sørensen from the ... more

Breaking bad: cancer cell drug addiction solved

Cancer cells can become not only resistant but also addicted to the drugs that serve to kill them. A research team led by professor Daniel Peeper from the Netherlands Cancer Institute has now discovered the underlying mechanism, which may guide the development of more rational alternating t ... more

Adjustment of drug dose for rheumatoid arthritis by diagnostic method

Determination of the therapeutic window of adalimumab

Collaboration between the Immanuel Klinikum Bernau Herzzentrum Brandenburg, the Rheumazentrum Nord-Brandenburg and BioTeZ demonstrates new ways of treating rheumatoid arthritis. Through the introduction of therapeutic antibodies, the treatment results for rheumatoid arthritis (RA) have been ... more

By decoding how HPV causes cancer, researchers find a new potential treatment strategy

A study that teases apart the biological mechanisms by which human papillomaviruses (HPV) cause cancer has found what researchers at Georgetown University Medical Center say is a new strategy that might provide targeted treatment for these cancers. HPV is responsible for the majority of cer ... more

All news on diagnostics

Integrated lab-on-a-chip uses smartphone to quickly detect multiple pathogens

A multidisciplinary group that includes the University of Illinois at Urbana-Champaign and the University of Washington at Tacoma has developed a novel platform to diagnose infectious disease at the point-of-care, using a smartphone as the detection instrument in conjunction with a test kit ... more

One if by editing, two if by roadblock

Human protein fights HIV as monomer and dimer

Fifteen years ago, a class of proteins was discovered, which give humans innate immunity to HIV-1. Unfortunately, HIV-1 is a smart virus and has evolved to battle these proteins. Northeastern researchers, with help from their collaborators, have been studying these proteins for several year ... more

Bacteria self-organize to build working sensors

Researchers at Duke University have turned bacteria into the builders of useful devices by programming them with a synthetic gene circuit. As a bacterial colony grows into the shape of a hemisphere, the gene circuit triggers the production of a type of protein to distribute within the colon ... more

Messe München acquires lab-technology trade fair Lab Africa

Expansion of the analytica network

Messe München bolsters its portfolio with the future market of Africa. By taking over Lab Africa, it is acquiring the only laboratory and analytics trade fair in South Africa, which is part of the analytica trade fair network. The first Lab Africa under the banner of Messe München will take ... more

A new twist on asymmetric catalysis

In the same way a glove will only fit one hand, molecules have the symmetry that controls their behavior and interactions. In drug design, this means reversing the symmetry of a molecule can mean the difference between an effective treatment or a compound that has serious negative effects. ... more

ZEISS Invests €30 Million in Innovation Hub at KIT

Long-term prospects for KIT carve-outs

ZEISS plans to build a new shared innovation hub on the north campus of the Karlsruhe Institute of Technology (KIT). Construction is scheduled to begin in early 2018; the €30 million hub will cover 12,000 square meters. With the ZEISS Innovation Hub, the global technology leader in optics a ... more

Virtual reality tool developed to untangle genes

Researchers from Oxford have been using virtual reality software to compile genetic data to create models which explain how genes are controlled within their natural chromosomal environments. The team from the MRC Weatherall Institute of Molecular Medicine (WIMM) have been working in collab ... more

Fluorescence microscopy on a chip -- no lenses required

Fluorescence microscopy gives researchers incredible power to illuminate the tiniest structures and capture the real-time activities of live cells by tagging biological molecules with a veritable rainbow of fluorescent dyes. This power comes at a cost: The technology can be expensive and ti ... more

Molecular Devices and Cytena Partner collaborate in single cell printing

Molecular Devices, LLC announced a partnership with Cytena GmbH to launch the CloneSelect™ Single-Cell Printer™ in North America. This system utilizes microfluidics-based technology and real-time image analysis to isolate single cells and provide visual documentation of monoclonality for us ... more

Sartorius Campus expands: Official opening of the new manufacturing facility for laboratory instruments

The largest single investment of Sartorius Campus totaling around 42 million euros

With its new facility for the manufacture of laboratory instruments, Sartorius provides high-quality production conditions and an advanced, efficient work environment. The biopharmaceutical and laboratory equipment supplier officially opened its approximately 42-million-euro new building as ... more

All news on lab technology

Merck Named a Top Employer by Science Magazine

Survey ranks Merck fourth among the world’s top employers

Merck announced it was ranked fourth among biotechnology and pharmaceutical companies worldwide by Science magazine, a leading peer-reviewed international scientific publication. This ranking marks the fourth year in a row Merck was named one of the top 20 employers in the healthcare and li ... more

Protecting patents by Native Americans

By using a novel patent strategy companies try to protect their intellectual property in the US. And this is how it works: Giving your patent to a body called “sovereign immunites” makes this patent not attackable to a patent review called IPR (inter partes review). A large pharmaceutical c ... more

STA Pharmaceutical to open new transition metal catalysis center

The center will allow STA to introduce transition metal catalyst-screening technology to their existing small molecule process development and manufacturing platform. STA Pharmaceutical, a WuXi AppTec company, has announced plans to launch a new transition metal catalysis center at their in ... more

Biesterfeld Spezialchemie: New business unit combines healthcare distribution activities

As part of its ongoing drive to develop market segment focus, Biesterfeld Spezialchemie is creating a new business unit for healthcare distribution. This move is a logical continuation of previous developments and will allow the distributor to effectively target this highly demanding market ... more

Lilly and CureVac Announce Global Collaboration to Develop mRNA Cancer Vaccines

CureVac to receive an upfront payment of $50 million and an equity investment of €45 million

Eli Lilly and Company and CureVac AG have announced a global immuno-oncology collaboration focused on the development and commercialization of up to five potential cancer vaccine products based on CureVac’s proprietary RNActive® technology. The companies will use messenger RNA (mRNA) techno ... more

Engineering antidotes to chemical weapons

Chemical weapons and other toxic agents including pesticides pose a serious health threat worldwide, whether they are deliberately released or emitted by accident from industrial chemical operations during processing, shipping, or storage. Jin Montclare, an associate professor in the Depart ... more

Plasticell and GSK sign collaboration agreement

Contains production of hematopoietic cells from iPSCs

Plasticell, the biotechnology company specialising in stem cell screening and cell therapy development, has entered into a collaboration with GSK to use its combinatorial stem cell screening technology, CombiCult®, to optimise the directed differentiation of induced pluripotent stem cells ( ... more

Magic mushrooms may 'reset' the brains of depressed patients

Patients taking psilocybin to treat depression show reduced symptoms weeks after treatment following a 'reset' of their brain activity. The findings come from a study in which researchers from Imperial College London used psilocybin - the psychoactive compound that occurs naturally in magic ... more

New antibiotic resistance genes found

Researchers at Chalmers University of Technology and the University of Gothenburg, Sweden, have found several previously unknown genes that make bacteria resistant to last-resort antibiotics. The genes were found by searching large volumes of bacterial DNA. The increasing number of infectio ... more

New tools to combat kidney fibrosis

Interstitial fibrosis – excessive tissue scarring – contributes to chronic kidney disease, which is increasing in prevalence in the United States. Raymond Harris , M.D., and colleagues have previously implicated the epidermal growth factor receptor (EGFR) in the pathogenesis of diabetic nep ... more

All news on pharma

Integrated lab-on-a-chip uses smartphone to quickly detect multiple pathogens

A multidisciplinary group that includes the University of Illinois at Urbana-Champaign and the University of Washington at Tacoma has developed a novel platform to diagnose infectious disease at the point-of-care, using a smartphone as the detection instrument in conjunction with a test kit ... more

Herbal remedies containing aristolochic acid may cause liver cancer

Scientists from Singapore and Taiwan have revealed a decisive link between Aristolochic Acids (AA), a natural product of some plants used in herbal remedies, and liver cancers. Using mutational signature analysis, the researchers found that liver tumours had been exposed to AA, which had mu ... more

Explaining how UV rays trigger skin cancer

Melanoma, a cancer of skin pigment cells called melanocytes, will strike an estimated 87,110 people in the U.S. in 2017, according to the Centers for Disease Control and Prevention. A fraction of those melanomas come from pre-existing moles, but the majority of them come from sources unknow ... more

Possible new immune therapy target in lung cancer

A study from Bern University Hospital in collaboration with the University of Bern shows that so-called perivascular-like cells from lung tumors behave abnormally. They not only inadequately support vascular structures, but also may actively modulate the inflammatory and immune response. Th ... more

Releasing the brakes on the immune system

Many tumors possess mechanisms to avoid destruction by the immune system. For instance, they misuse the natural “brakes” in the immune defense mechanism, which normally prevent an excessive immune response. Researchers at the University of Bonn have now been able to take off one of these br ... more

Initiative taps scientists to create atlas of cells in human spinal cord

Scientists at Columbia's Zuckerman Institute today received a grant from the Chan Zuckerberg Initiative (CZI) donor advised fund, an advised fund of the Silicon Valley Community Foundation, to construct an atlas of gene activity of all cells in the human spinal cord. Once completed, the atl ... more

Engineering antidotes to chemical weapons

Chemical weapons and other toxic agents including pesticides pose a serious health threat worldwide, whether they are deliberately released or emitted by accident from industrial chemical operations during processing, shipping, or storage. Jin Montclare, an associate professor in the Depart ... more

Plasticell and GSK sign collaboration agreement

Contains production of hematopoietic cells from iPSCs

Plasticell, the biotechnology company specialising in stem cell screening and cell therapy development, has entered into a collaboration with GSK to use its combinatorial stem cell screening technology, CombiCult®, to optimise the directed differentiation of induced pluripotent stem cells ( ... more

Mechanism explains how seizures may lead to memory loss

Although it's been clear that seizures are linked to memory loss and other cognitive deficits in patients with Alzheimer's disease, how this happens has been puzzling. In a study a team of researchers reveals a mechanism that can explain how even relatively infrequent seizures can lead to l ... more

Proteins may prevent dysfunction and disease by relaxing

For many years, we thought that all proteins must fold into complicated shapes to fulfill their functions, looking like thousands of sets of custom-tailored locks and keys. But over the past two decades, scientists have begun to realize other proteins -- including those involved in many ess ... more

All news on healthcare
News by department
  • Products

    Lilly and CureVac Announce Global Collaboration to Develop mRNA Cancer Vaccines

    CureVac to receive an upfront payment of $50 million and an equity investment of €45 million

    Eli Lilly and Company and CureVac AG have announced a global immuno-oncology collaboration focused on the development and commercialization of up to five potential cancer vaccine products based on CureVac’s proprietary RNActive® technology. The companies will use messenger RNA (mRNA) techno ... more

    Pertinax Pharma launches patented chlorhexidine technology

    Novel materials enable controlled and sustained release of chlorhexidine

    Pertinax Pharma today announces the commercial launch of its unique, proprietary Pertinax® technology, which provides controlled and sustained delivery of chlorhexidine (CHX). The revolutionary new technology has a wide range of potential applications across the wound care, dentistry, medic ... more

    OMEICOS Secures Extension of Series B Financing Round

    OMEICOS Therapeutics, a Berlin-based biopharmaceutical company developing first-in-class small molecule therapeutics for the prevention and treatment of cardiovascular diseases, today announced that it has secured an extension of its recently closed Series B financing round. The financing b ... more

  • Business

    Protecting patents by Native Americans

    By using a novel patent strategy companies try to protect their intellectual property in the US. And this is how it works: Giving your patent to a body called “sovereign immunites” makes this patent not attackable to a patent review called IPR (inter partes review). A large pharmaceutical c ... more

    Innovative Extraction Technologies

    Getting More From Biomass

    Swedish-Finnish company Stora Enso is undergoing a renewable materials transformation. Previously focused on pulp and paper, the company is developing new, innovative products and services based on wood and other non-food competing feedstock. The goal – to replace non-renewable materials an ... more

    STA Pharmaceutical to open new transition metal catalysis center

    The center will allow STA to introduce transition metal catalyst-screening technology to their existing small molecule process development and manufacturing platform. STA Pharmaceutical, a WuXi AppTec company, has announced plans to launch a new transition metal catalysis center at their in ... more

  • Price Development

    Drug costs vary by more than 600% in study of 10 high-income countries

    In a study of 10 high-income countries with universal health care, costs for prescription drugs in 6 of the largest categories of primary care medicines varied by more than 600%. All countries except Canada offered universal coverage of outpatient prescription drugs. The study looked at dat ... more

    Cell Medica granted Orphan Drug designation for novel cellular therapy

    Cell Medica announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to the company’s cancer immunotherapy treatment, referred to as CMD-003, under development for Epstein-Barr Virus (EBV) positive non-Hodgkin lymphomas. Additionally, the company announ ... more

    BASF increases prices for Vitamin E and A feed grade

    BASF increases prices for Vitamin E and A products for animal nutrition globally and with immediate effect. Prices will increase by 15% for all Vitamin E products and by 10% for all Vitamin A products. Existing contractual obligations with customers will be honored. more

  • Research

    Integrated lab-on-a-chip uses smartphone to quickly detect multiple pathogens

    A multidisciplinary group that includes the University of Illinois at Urbana-Champaign and the University of Washington at Tacoma has developed a novel platform to diagnose infectious disease at the point-of-care, using a smartphone as the detection instrument in conjunction with a test kit ... more

    Herbal remedies containing aristolochic acid may cause liver cancer

    Scientists from Singapore and Taiwan have revealed a decisive link between Aristolochic Acids (AA), a natural product of some plants used in herbal remedies, and liver cancers. Using mutational signature analysis, the researchers found that liver tumours had been exposed to AA, which had mu ... more

    Explaining how UV rays trigger skin cancer

    Melanoma, a cancer of skin pigment cells called melanocytes, will strike an estimated 87,110 people in the U.S. in 2017, according to the Centers for Disease Control and Prevention. A fraction of those melanomas come from pre-existing moles, but the majority of them come from sources unknow ... more

  • People

    Heptares founder Richard Henderson receives Nobel Prize in Chemistry 2017

    Heptares Therapeutics is delighted that one of its founders, Richard Henderson (MRC Laboratory of Molecular Biology, Cambridge, UK), was awarded the Nobel Prize in Chemistry 2017 together with Jacques Dubochet (University of Lausanne, Switzerland) and Joachim Frank (Columbia University, New ... more

    The Nobel Prize Winners 2017

    Internal clock, gravitational waves and cold analysis

    This year's Nobel Prizes were awarded to a total of nine scientists. The research areas that have been awarded and the prize winners at a glance: Nobel Prize for Physiology or Medicine The Nobel Committee at the Karolinska Institute has awarded the Nobel Prize in Physiology or Medicine to t ... more

    Cool microscope technology revolutionises biochemistry

    We may soon have detailed images of life’s complex machineries in atomic resolution. The Nobel Prize in Chemistry 2017 is awarded to Jacques Dubochet, Joachim Frank and Richard Henderson for the development of cryo-electron microscopy, which both simplifies and improves the imaging of biomo ... more

  • Finances

    SimPath licenses novel ORNL system for enhanced synthetic biology

    SimPath has licensed a novel cloning system developed by the Department of Energy's Oak Ridge National Laboratory that generates and assembles the biological building blocks necessary to synthetically bioengineer new medicines and fuels. Knoxville, Tennessee-based startup SimPath will furth ... more

    VirionHealth Raises Series A Funding from Abingworth

    VirionHealth Ltd, a new biotechnology company developing novel therapeutics for respiratory viral infections, today announced that it has raised up to £13 million in Series A funding from Abingworth, the international investment group dedicated to life sciences. VirionHealth, founded on pio ... more

    Eurofins acquires LGC Forensics

    Eurofins Scientific announces that it has signed an agreement to acquire the Forensics and Security division of LGC (“LGC Forensics”), the largest player in the UK forensics market, a European pioneer in this field and a significant forensic DNA testing provider in Germany, from LGC Group. ... more

  • Cooperation

    Lilly and CureVac Announce Global Collaboration to Develop mRNA Cancer Vaccines

    CureVac to receive an upfront payment of $50 million and an equity investment of €45 million

    Eli Lilly and Company and CureVac AG have announced a global immuno-oncology collaboration focused on the development and commercialization of up to five potential cancer vaccine products based on CureVac’s proprietary RNActive® technology. The companies will use messenger RNA (mRNA) techno ... more

    SimPath licenses novel ORNL system for enhanced synthetic biology

    SimPath has licensed a novel cloning system developed by the Department of Energy's Oak Ridge National Laboratory that generates and assembles the biological building blocks necessary to synthetically bioengineer new medicines and fuels. Knoxville, Tennessee-based startup SimPath will furth ... more

    Plasticell and GSK sign collaboration agreement

    Contains production of hematopoietic cells from iPSCs

    Plasticell, the biotechnology company specialising in stem cell screening and cell therapy development, has entered into a collaboration with GSK to use its combinatorial stem cell screening technology, CombiCult®, to optimise the directed differentiation of induced pluripotent stem cells ( ... more

  • Technology

    Integrated lab-on-a-chip uses smartphone to quickly detect multiple pathogens

    A multidisciplinary group that includes the University of Illinois at Urbana-Champaign and the University of Washington at Tacoma has developed a novel platform to diagnose infectious disease at the point-of-care, using a smartphone as the detection instrument in conjunction with a test kit ... more

    Protecting patents by Native Americans

    By using a novel patent strategy companies try to protect their intellectual property in the US. And this is how it works: Giving your patent to a body called “sovereign immunites” makes this patent not attackable to a patent review called IPR (inter partes review). A large pharmaceutical c ... more

    Explaining how UV rays trigger skin cancer

    Melanoma, a cancer of skin pigment cells called melanocytes, will strike an estimated 87,110 people in the U.S. in 2017, according to the Centers for Disease Control and Prevention. A fraction of those melanomas come from pre-existing moles, but the majority of them come from sources unknow ... more

  • Laws

    EPA to Grant Merck’s Patent Application for CRISPR Technology

    Related patent application recently awarded in Australia

    Merck announced the European Patent Office (EPO) has issued a “Notice of Intention to Grant” for Merck’s patent application covering the company’s CRISPR technology used in a genomic integration method for eukaryotic cells. The patent will provide Merck’s CRISPR genomic integration technolo ... more

    EMA prepares for Brexit

    Business continuity plan aims to preserve Agency’s ability to protect public and animal health

    The European Medicines Agency (EMA) has developed and initiated a business continuity plan to deal with the uncertainty and workload implications linked to the United Kingdom’s (UK’s) withdrawal from the European Union (EU) and the Agency’s relocation. “Preparing for the move, managing the ... more

    New ISPE Good Practice Guide

    Decommissioning of Pharmaceutical Equipment and Facilities

    The International Society for Pharmaceutical Engineering (ISPE) announced the release of their latest guidance document, ISPE Good Practice Guide: Decommissioning of Pharmaceutical Equipment and Facilities. This guide provides an overview of best practices to be used for the decommissioning ... more

  • Market

    Innovative Extraction Technologies

    Getting More From Biomass

    Swedish-Finnish company Stora Enso is undergoing a renewable materials transformation. Previously focused on pulp and paper, the company is developing new, innovative products and services based on wood and other non-food competing feedstock. The goal – to replace non-renewable materials an ... more

    STA Pharmaceutical to open new transition metal catalysis center

    The center will allow STA to introduce transition metal catalyst-screening technology to their existing small molecule process development and manufacturing platform. STA Pharmaceutical, a WuXi AppTec company, has announced plans to launch a new transition metal catalysis center at their in ... more

    Evonik opens site in France’s Cosmetic Valley

    At the end of September, Evonik celebrated the opening of the new site for its Evonik Advanced Botanicals subsidiary in Tours (France). Now part of the Personal Care Business Line, the new subsidiary was created in 2016 when Evonik acquired experts in biotechnological production of plant-ba ... more

  • Politics

    Protecting patents by Native Americans

    By using a novel patent strategy companies try to protect their intellectual property in the US. And this is how it works: Giving your patent to a body called “sovereign immunites” makes this patent not attackable to a patent review called IPR (inter partes review). A large pharmaceutical c ... more

    FDA approval brings first gene therapy to the United States

    The U.S. Food and Drug Administration issued a historic action today making the first gene therapy available in the United States, ushering in a new approach to the treatment of cancer and other serious and life-threatening diseases. The FDA approved Kymriah (tisagenlecleucel) for certain p ... more

    EPA to Grant Merck’s Patent Application for CRISPR Technology

    Related patent application recently awarded in Australia

    Merck announced the European Patent Office (EPO) has issued a “Notice of Intention to Grant” for Merck’s patent application covering the company’s CRISPR technology used in a genomic integration method for eukaryotic cells. The patent will provide Merck’s CRISPR genomic integration technolo ... more

  • Manufacturing

    Innovative Extraction Technologies

    Getting More From Biomass

    Swedish-Finnish company Stora Enso is undergoing a renewable materials transformation. Previously focused on pulp and paper, the company is developing new, innovative products and services based on wood and other non-food competing feedstock. The goal – to replace non-renewable materials an ... more

    STA Pharmaceutical to open new transition metal catalysis center

    The center will allow STA to introduce transition metal catalyst-screening technology to their existing small molecule process development and manufacturing platform. STA Pharmaceutical, a WuXi AppTec company, has announced plans to launch a new transition metal catalysis center at their in ... more

    Sanofi invests in new vaccine production facility in France

    Sanofi is investing €170 million to expand a vaccine manufacturing site in Val de Reuil, France. The expansion further strengthens Sanofi's position as one of the world's leading seasonal flu vaccine providers. The new facility will allow Sanofi Pasteur, the Vaccines global business unit of ... more

  • Career

    Merck Named a Top Employer by Science Magazine

    Survey ranks Merck fourth among the world’s top employers

    Merck announced it was ranked fourth among biotechnology and pharmaceutical companies worldwide by Science magazine, a leading peer-reviewed international scientific publication. This ranking marks the fourth year in a row Merck was named one of the top 20 employers in the healthcare and li ... more

    To be or not to be an academic: the question for all postdocs

    Becoming a full time academic at a research university is not an easy road.

    Becoming a full time academic at a research university is a dream for many young scientists, but it's not an easy road. For the past eight years, Dr Liz Elvidge has been helping postdoctoral researchers achieve this goal − but also advising them about a variety of different career paths and ... more

    Being fit Protects Against Health Risks Caused by Stress at Work

    It is a well-known fact that fitness and well-being go hand in hand. But being in good shape also protects against the health problems that arise when we feel particularly stressed at work. As reported by sports scientists from the University of Basel and colleagues from Sweden, it therefor ... more

News according to country
News archive
Newsletters

bionity.com Newsletter

The bionity.com newsletter keeps you informed about the current events in the fields of biotechnology, life sciences and medicine with news, products, company profiles and technical information.
Current edition

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE